MAX TUSSIN MUCUS AND CHEST CONGESTION- guaifenesin liquid

MAX Tussin Mucus and Chest Congestion by

Drug Labeling and Warnings

MAX Tussin Mucus and Chest Congestion by is a Otc medication manufactured, distributed, or labeled by Akron Pharma Inc., HI-TECH PHARMACEUTICALS PRIVATE LIMITED. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients (in each 10 mL)

Guaifenesin 200 mg

Purposes

Expectorant

Uses

• helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive

Warnings

Ask a doctor before use if you have

• cough that occurs with too much phlegm (mucus)
• cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema

Stop use and ask a doctor if

cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

• do not take more than 6 doses in any 24-hour period
• measure only with dosing cup provided
• mL= milliliter
• this adult product is not intended for use in children under 12 years of age

• age: dose
• adults and children 12 years and over: 10 - 20 mL every 4 hours
• children under 12 years: do not use

Other information

• Phenylketonurics: contains Phenylalanine 30 mg per 10 mL
• store at 20-25ºC(68-77ºF). Do not refrigerate

Inactive ingredients

anhydrous citric acid, flavor cherry, glycerin, menthol, purified water, saccharin sodium, sodium benzoate, sorbitol solution, sucralose, sucrose.

Questions or comments?

toll-free 1-877-225-6999

Manufactured for:

Akron Pharma, Inc.

Fairfield, NJ 07004

www.akronpharma.com

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

MAX TUSSIN MUCUS AND CHEST CONGESTION 
guaifenesin liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71399-0054
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ)	GUAIFENESIN	200 mg  in 10 mL

Inactive Ingredients
Ingredient Name	Strength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
GLYCERIN (UNII: PDC6A3C0OX)
MENTHOL (UNII: L7T10EIP3A)
WATER (UNII: 059QF0KO0R)
SACCHARIN SODIUM (UNII: SB8ZUX40TY)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SORBITOL SOLUTION (UNII: 8KW3E207O2)
SUCRALOSE (UNII: 96K6UQ3ZD4)
SUCROSE (UNII: C151H8M554)

Product Characteristics
Color		Score
Shape		Size
Flavor	CHERRY	Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71399-0054-8	1 in 1 PACKAGE	11/03/2023
1		236 mL in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC: 71399-0054-4	1 in 1 PACKAGE	11/03/2023
2		118 mL in 1 BOTTLE; Type 0: Not a Combination Product
3	NDC: 71399-0054-6	473 mL in 1 BOTTLE; Type 0: Not a Combination Product	11/03/2023

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M012	11/03/2023

Labeler - Akron Pharma Inc. (067878881)